Glycosylated hemoglobin, but not advanced glycation end products, predicts severity of coronary artery disease in patients with or without diabetes
Background: The association between coronary artery disease (CAD) and diabetes mellitus (DM) is strong but the physiologic mechanisms responsible for this association remain unclear. Patients with DM exhibit high circulating levels of glycated proteins and lipoproteins called advanced glycation end...
Main Authors: | Craig Basman, Sarah L. Fishman, Dimiter Avtanski, Umar Rashid, Arber Kodra, Karin Chen, Rebecca Jonas, Guillaume J. Stoffels, Martin Lesser, Damian Inlall, Karina Ziskovich, Varinder Singh, Leonid Poretsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Metabolism Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258993682030030X |
Similar Items
-
Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts
by: Julio A. Lamprea‐Montealegre, et al.
Published: (2022-08-01) -
Galectin‐3 and RAGE differentially control advanced glycation endproduct‐induced collagen damage in murine intervertebral disc organ culture
by: Zachary S. Gallate, et al.
Published: (2023-06-01) -
The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
by: Matthew Snelson, et al.
Published: (2022-02-01) -
Studies about the Dietary Impact on “Free” Glycation Compounds in Human Saliva
by: Friederike Manig, et al.
Published: (2022-07-01) -
Usefulness of glycated albumin level as a glycemic index complementing glycosylated hemoglobin in diabetic children and adolescents
by: Young Ju Choi, et al.
Published: (2023-12-01)